The FDA recently authorized a level C qualified health claim for high-amylose maize resistant starch and a reduced risk of type 2 diabetes. The CDC reports that 1 in 3 American adults have prediabetes and are at risk for developing type 2 diabetes1—with 60% of consumers interested in buying foods that help them “reduce the risk of type 2 diabetes”2. Learn about this qualified health claim, and find out how HI-MAIZE® resistant starch can help you create innovative products.
2 Ingredion proprietary consumer research
Maria Stewart, PhD
Clinical Research Lead, Global Nutrition R&D
Santiago Vega, MBA
Senior Marketing Manager, Nutrition North America